Ozempic, for example, is typically initiated at a dose of 0.25 mg once a week, with gradual escalations to 0.5 mg, 1 mg, and up to 2 mg, depending on the patient's response and tolerance
Continuous flow peptide synthesis is moving from laboratory demonstration to commercial application
A real-world comparison of cardiovascular, medical and costs outcomes in new users of SGLT2 inhibitors versus GLP-1 agonists
3.4 Liraglutide promotes insulin secretion in lipodystrophic mice Liraglutide, and GLP-1 agonists more broadly, have been shown to improve cell function by promoting insulin secretion, cell survival and cell proliferation (12, 13, 3739)
& Drasdo, D